With a mission to create the most advanced digital diagnostic laboratory network enabling the connected world and to provide telemedicine and instant care, DIVOC Health launched its first, one-of-a-kind, technologically advanced DIVOC Laboratories in New Delhi in August 2020.

Within a month of its establishment, DIVOC Lab in New Delhi has over 100 patients each day and aims to be of assistance to 500-600 patients daily by the next 90 days. The laboratory has already been accredited by NABL and ICMR and have all tests and diagnosis available including COVID-19.

Now successfully operational and gaining trust of many, DIVOC Labs is all set to expand its footprints in India. DIVOC Wellness sponsored by Venture Capitalist Impact Financing from London, England. They are preparing to open 20 labs across Tier II and Tier III cities like Lucknow, Bhopal and Jaipur, etc. The focus of the expansion will be on developing more number of ‘Labs of the Future’ where patients have access to instant diagnosis and results at the doorstep within minutes. This will support the growing demand for high-level testing in India and empower the telemedicine segment in faster patient care.

Dr Kanav Kahol, CEO, DIVOC Health, says, “We are working on a unique platform that will allow phlebotomists to double their income. We aim to provide a modern, quality driven digital approach to laboratory operations that facilitate consumers with unprecedented reliability, convenience, and impactful innovations.”

DIVOC Lab has setup a state of the art facility in Okhla, New Delhi which can enable a variety of testing. The lab of the future has collaborated with United Kingdom laboratories to bring 21st century innovations into diagnostics. It offers Clinical Chemistry, Clinical Microbiology, Haematology, Serology, Clinical Microscopy, Cytopathology and Molecular Biology. It also offers TRUNAAT, RT PCR and Antigen COVID Testing pending ICMR notifications and approvals.

DIVOC Laboratories, formed by leading global health experts and practitioners, envisions enabling a digitally empowered integrated approach to diagnostics. It has also introduced at-home, instant diagnostics which would allow phlebotomists to conduct testing and deliver results right away.